Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1978 1
1986 2
1989 1
1990 2
1993 2
1994 1
1995 1
1997 1
1999 2
2000 1
2001 1
2003 3
2004 2
2005 1
2006 4
2007 2
2008 4
2009 3
2010 10
2011 5
2012 5
2013 6
2014 5
2015 1
2016 5
2017 3
2018 6
2019 4
2020 4
2021 6
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Garon EB, Ciuleanu TE, Arrieta O, Prabhash K, Syrigos KN, Goksel T, Park K, Gorbunova V, Kowalyszyn RD, Pikiel J, Czyzewicz G, Orlov SV, Lewanski CR, Thomas M, Bidoli P, Dakhil S, Gans S, Kim JH, Grigorescu A, Karaseva N, Reck M, Cappuzzo F, Alexandris E, Sashegyi A, Yurasov S, Pérol M. Garon EB, et al. Among authors: orlov sv. Lancet. 2014 Aug 23;384(9944):665-73. doi: 10.1016/S0140-6736(14)60845-X. Epub 2014 Jun 2. Lancet. 2014. PMID: 24933332 Clinical Trial.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
Wolf J, Seto T, Han JY, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, Smit EF, Souquet PJ, Vansteenkiste J, Hochmair M, Felip E, Nishio M, Thomas M, Ohashi K, Toyozawa R, Overbeck TR, de Marinis F, Kim TM, Laack E, Robeva A, Le Mouhaer S, Waldron-Lynch M, Sankaran B, Balbin OA, Cui X, Giovannini M, Akimov M, Heist RS; GEOMETRY mono-1 Investigators. Wolf J, et al. Among authors: orlov sv. N Engl J Med. 2020 Sep 3;383(10):944-957. doi: 10.1056/NEJMoa2002787. N Engl J Med. 2020. PMID: 32877583 Clinical Trial.
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
Kelly K, Altorki NK, Eberhardt WE, O'Brien ME, Spigel DR, Crinò L, Tsai CM, Kim JH, Cho EK, Hoffman PC, Orlov SV, Serwatowski P, Wang J, Foley MA, Horan JD, Shepherd FA. Kelly K, et al. Among authors: orlov sv. J Clin Oncol. 2015 Dec 1;33(34):4007-14. doi: 10.1200/JCO.2015.61.8918. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324372 Clinical Trial.
Composition of Bacteriophages for Therapeutic and Prophylactic Use in Monkeys.
Cherkashina EV, Arshba IM, Demerchyan AV, Polyakova VI, Rubalsky OV, Bochkareva SS, Aleshkin AV, Ruemke S, Kuehn C, Haverich A, Rubalskii EO, Orlov SV. Cherkashina EV, et al. Among authors: orlov sv. Bull Exp Biol Med. 2023 Jan;174(3):376-379. doi: 10.1007/s10517-023-05711-7. Epub 2023 Feb 1. Bull Exp Biol Med. 2023. PMID: 36723746
[Adiponectin in normal and atherosclerotic intima of human aorta].
Tanyanskiy DA, Pigarevskii PV, Maltseva SV, Malashicheva AB, Docshin PM, Uspenskiy VE, Lizunov AV, Orlov SV, Maltseva ON, Ageeva EV, Denisenko AD. Tanyanskiy DA, et al. Among authors: orlov sv. Arkh Patol. 2022;84(6):16-22. doi: 10.17116/patol20228406116. Arkh Patol. 2022. PMID: 36469713 Russian.
Differentiation of human macrophages with anaphylatoxin C3a impairs alternative M2 polarization and decreases lipopolysaccharide-induced cytokine secretion.
Mogilenko DA, Danko K, Larionova EE, Shavva VS, Kudriavtsev IV, Nekrasova EV, Burnusuz AV, Gorbunov NP, Trofimov AV, Zhakhov AV, Ivanov IA, Orlov SV. Mogilenko DA, et al. Among authors: orlov sv. Immunol Cell Biol. 2022 Mar;100(3):186-204. doi: 10.1111/imcb.12534. Epub 2022 Mar 4. Immunol Cell Biol. 2022. PMID: 35148436
99 results